Key result
Surgical RF ablation is linked to reduced coronary sinus norepinephrine, with a ~400 pg/mL drop predicting denervation.
Why the study?
Does surgical radiofrequency ablation affect neurohumoral transmitter levels and myocardial 123I-MIBG uptake in patients with acquired valvular heart disease and persistent atrial fibrillation?
Observational
Does surgical radiofrequency ablation affect neurohumoral transmitter levels and myocardial 123I-MIBG uptake in patients with acquired valvular heart disease and persistent atrial fibrillation?
Intraoperative differences in norepinephrine levels between the ascending aorta and coronary sinus can predict the efficacy of cardiac autonomic denervation during the MAZE-IV procedure.
May guide intraoperative denervation assessment in MAZE-IV; leaves open effects on AF outcomes in valvular disease.
Although the autonomic nervous system has an evident impact on cardiac electrophysiology and radiofrequency ablation (RFA) is the conventional technique for treating persistent atrial fibrillation, the specific effects of RFA have been insufficiently studied to date. Here, we investigated whether RFA affects neurohumoral transmitter levels and myocardial 123I-metaiodobenzylguanidine (123I-MIBG) uptake. To perform this task, we compared two groups of patients with acquired valvular heart disease: patients who had undergone surgical AF ablation and patients with sinus rhythm. The decrease in norepinephrine (NE) level in the coronary sinus had a direct association with the heart-to-mediastinum ratio (p = 0.02) and a negative correlation with 123I-MIBG uptake defects (p = 0.01). The NE level decreased significantly after the main surgery, both in patients with AF (p = 0.0098) and sinus rhythm (p = 0.0039). Furthermore, the intraoperative difference between the norepinephrine levels in the ascending aorta and coronary sinus (ΔNE) of –400 pg/mL was determined as a cut-off value to evaluate RFA efficacy, as denervation failed in all patients with ΔNE < –400 pg/mL. Hence, ΔNE can be utilized to predict the efficacy of the “MAZE-IV” procedure and to assess the risk of AF recurrence after RFA.
No takes yet. Share an insight, caveat, or question.
Евтушенко et al. (2023) conducted an observational in Long-standing persistent atrial fibrillation and acquired valvular heart disease. Surgical radiofrequency ablation (MAZE-IV) vs. Sinus rhythm (no AF ablation) was evaluated on Neurohumoral transmitter (norepinephrine) levels and myocardial 123I-MIBG uptake. Surgical radiofrequency ablation significantly decreased coronary sinus norepinephrine levels, with an intraoperative ΔNE cut-off of –400 pg/mL predicting denervation efficacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: